|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/337 | |
| A61K 31/573 | |||
| A61P 35/00 |
| (11) | Number of the document | 3258931 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16714575.4 |
| Date of filing the European patent application | 2016-02-17 | |
| (97) | Date of publication of the European application | 2017-12-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/NL2016/050111 |
| Date | 2016-02-17 |
| (87) | Number | WO 2016/133387 |
| Date | 2016-08-25 |
| (30) | Number | Date | Country code |
| 15155470 | 2015-02-17 | EP |
| (72) |
SLEIJFER, Stefan, NL
ONSTENK, Wendy, NL
SIEUWERTS, Anita Maria, NL
|
| (73) |
Erasmus University Medical Center Rotterdam,
Dr. Molewaterplein 50, 3015 GE Rotterdam,
NL
|
| (54) | USE OF CABAZITAXEL IN THE TREATMENT OF PROSTATE CANCER |
| USE OF CABAZITAXEL IN THE TREATMENT OF PROSTATE CANCER |